Cytokeratin 5 antibody (AA 318-491)
Quick Overview for Cytokeratin 5 antibody (AA 318-491) (ABIN7873899)
Target
See all Cytokeratin 5 (KRT5) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 318-491
-
Purpose
- Cytokeratin 5 Antibody / KRT5
-
Purification
- Culture supernatant
-
Immunogen
- A recombinant human partial protein (amino acids 318-491) was used as the immunogen for this Cytokeratin 5 antibody.
-
Isotype
- IgG1, kappa
-
-
-
-
Application Notes
- Optimal dilution of the Cytokeratin 5 antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Culture supernatant with 0.05 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store the Cytokeratin 5 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- Cytokeratin 5 (KRT5) (Keratin 5 (KRT5))
-
Alternative Name
- Cytokeratin 5
-
Background
- This MAb recognizes a protein of 58 kDa, which is identified as Cytokeratin 5 (KRT5). This type II cytokeratin is specifically expressed in the basal layer of the epidermis with family member KRT14. Antibodies to KRT5 identify basal cells of squamous and glandular epithelia, myoepithelia, and mesothelium. Anti-cytokeratin 5 has been reported useful in the differential diagnosis of metastatic carcinoma in the pleura versus epithelioid mesothelioma. Almost all squamous cell carcinomas, half of transitional carcinomas, and many undifferentiated large cell carcinomas express. Anti-KRT5, along with anti-p63, affords a high sensitivity and specificity for squamous differentiation. Myoepithelial cells of the breast, glandular epithelia, and basal cells of the prostate are labeled with anti-KRT5.
-
UniProt
- P13647
Target
-